*** Please note this program was a part of the MOA 's 2025 Midwinter Symposium. You will not want to choose this program if you completed this individual program as part of the MOA 2025 Midwinter Symposium. ***
Objectives– Following this lecture participants will be able to:
1. Participants will feel confident in prescribing buprenorphine for patients with opioid use disorder
2. Participants will learn 3 methods of at home initiation of buprenorphine
3. Participants will be able to anticipate, and manage, complications of buprenorphine initiation
This session is accredited for a maximum of 1.0 AOA Category 1-A credits and 1.0 credits for The Prescribing of Controlled Substances. Credits commensurate with participation in the session will be awarded.
MOA Grievance Policy: All grievances should be initially directed in writing to the MOA Executive Director by email to info@mainedo.org who will share them with the MOA's Program Committee. Grievances will receive a response within 30 days of receipt. If you do not receive a satisfactory response, you may notify the Council on Continuing Medical Education, AOA, 142 East Ontario St., Chicago, IL 60611.